definiens: shall mean Patent Rights owned or Controlled by a Party which relate to the composition or use of rei ) ( a ) a CRFI Receptor Antagonist / Agonist that is within the [COMPANY] Contributed Technology, the A ventis Contributed Technology or the Joint Technology and ( b ) assert a priority date no later than twelve ( 12 ) months after the expiration of the Research Program, ( ij ) a CRFI Receptor Antagonist / Agonist that is required to be recorded by the Party on the list specified in Section 13.7, other than Unavailable Compounds, or ( iii ) a CRFI Receptor Antagonist / Agonist that would be an ( as such term is used in 35 USC § 1 03(a ) ) variant of a Compound described in preceding clause ii . other than Unavailable Compounds ) . Notwithstanding the foregoing, in no event shall CRF I Patent Rights include any rights obtained by A ventis to participate in the development or commercialization of an [ Ex­Program Product )